Compare CCL INTERNATIONAL with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CCL INTERNATIONAL vs INDOCO REMEDIES - Comparison Results

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CCL INTERNATIONAL INDOCO REMEDIES CCL INTERNATIONAL/
INDOCO REMEDIES
 
P/E (TTM) x 37.3 128.4 29.1% View Chart
P/BV x 2.0 2.2 94.8% View Chart
Dividend Yield % 0.6 0.6 100.5%  

Financials

 CCL INTERNATIONAL   INDOCO REMEDIES
EQUITY SHARE DATA
    CCL INTERNATIONAL
Mar-15
INDOCO REMEDIES
Mar-18
CCL INTERNATIONAL/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs487317 153.4%   
Low Rs266178 149.5%   
Sales per share (Unadj.) Rs9.8113.1 8.7%  
Earnings per share (Unadj.) Rs0.14.5 2.4%  
Cash flow per share (Unadj.) Rs0.211.8 2.0%  
Dividends per share (Unadj.) Rs0.051.00 5.0%  
Dividend yield (eoy) %00.4 3.3%  
Book value per share (Unadj.) Rs3.873.2 5.2%  
Shares outstanding (eoy) m95.9692.15 104.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x38.32.2 1,748.0%   
Avg P/E ratio x3,518.455.5 6,343.2%  
P/CF ratio (eoy) x1,566.321.0 7,469.0%  
Price / Book Value ratio x98.03.4 2,896.7%  
Dividend payout %46.722.4 208.7%   
Avg Mkt Cap Rs m36,13422,830 158.3%   
No. of employees `000NA5.5 0.0%   
Total wages/salary Rs m112,209 0.5%   
Avg. sales/employee Rs ThNM1,910.1-  
Avg. wages/employee Rs ThNM405.0-  
Avg. net profit/employee Rs ThNM75.5-  
INCOME DATA
Net Sales Rs m94310,419 9.1%  
Other income Rs m647 12.4%   
Total revenues Rs m94910,466 9.1%   
Gross profit Rs m351,349 2.6%  
Depreciation Rs m13677 1.9%   
Interest Rs m13235 5.6%   
Profit before tax Rs m15484 3.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m572 6.7%   
Profit after tax Rs m10412 2.5%  
Gross profit margin %3.712.9 28.8%  
Effective tax rate %32.015.0 213.8%   
Net profit margin %1.14.0 27.6%  
BALANCE SHEET DATA
Current assets Rs m3155,373 5.9%   
Current liabilities Rs m2244,157 5.4%   
Net working cap to sales %9.611.7 82.0%  
Current ratio x1.41.3 108.5%  
Inventory Days Days5868 85.8%  
Debtors Days Days673 8.4%  
Net fixed assets Rs m2126,244 3.4%   
Share capital Rs m192184 104.1%   
"Free" reserves Rs m1776,566 2.7%   
Net worth Rs m3696,750 5.5%   
Long term debt Rs m341,233 2.7%   
Total assets Rs m63212,363 5.1%  
Interest coverage x2.23.1 70.4%   
Debt to equity ratio x0.10.2 49.9%  
Sales to assets ratio x1.50.8 177.1%   
Return on assets %3.75.2 70.7%  
Return on equity %2.86.1 45.7%  
Return on capital %7.09.0 77.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m03,762 0.0%   
Fx outflow Rs m01,143 0.0%   
Net fx Rs m02,619 0.0%   
CASH FLOW
From Operations Rs m141,227 1.2%  
From Investments Rs m14-1,360 -1.0%  
From Financial Activity Rs m-1-388 0.2%  
Net Cashflow Rs m27-521 -5.2%  

Share Holding

Indian Promoters % 44.6 59.2 75.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 12.5 -  
FIIs % 0.2 6.0 3.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 55.3 22.4 246.9%  
Shareholders   1,958 12,805 15.3%  
Pledged promoter(s) holding % 2.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CCL INTERNATIONAL With:   TATA INVESTMENT  EDELWEISS FINANCIAL  IL&FS INV. MANAGERS  CREST VENTURES  TIL  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

CCL INTERNATIONAL Announces Quarterly Results (3QFY19); Net Profit Down 75.9% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, CCL INTERNATIONAL has posted a net profit of Rs 1 m (down 75.9% YoY). Sales on the other hand came in at Rs 97 m (down 5.1% YoY). Read on for a complete analysis of CCL INTERNATIONAL's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, INDOCO REMEDIES has posted a net profit of Rs 53 m (down 76.4% YoY). Sales on the other hand came in at Rs 3 bn (down 5.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CCL INTERNATIONAL SHARE PRICE


Sep 20, 2019 (Close)

TRACK CCL INTERNATIONAL

  • Track your investment in CCL INTERNATIONAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CCL INTERNATIONAL

CCL INTERNATIONAL 8-QTR ANALYSIS

COMPARE CCL INTERNATIONAL WITH

MARKET STATS